HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

The article highlights the potentially game-changing approach of the Company towards treating Alzheimer’s Disease, based on technology developed at Rutgers by Dr. Luciano D’Adamio, PhD, MD, New Jersey ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The acquisition will augment Gate Neurosciences’ existing translational research in synaptic function pharmacology ... next-generation precision CNS treatments that address growing needs ...

Gate Neurosciences today announced it has entered a definitive agreement to acquire Boost Neuroscience and its leading proprietary platform for human synapse network analysis and synapse-targeted drug ...

That is the number of women in the United States that have reported completed or attempted rape during their lifetime — 21% of the population, about 1 in every 5 women [1].

Department of Pharmacology and Toxicology, National Institutes of Pharmaceutical Education and Research (NIPER), organised a workshop on “Drug discovery and development in mew Millennium- 4” (D3NM-4) ...

Thanks to its capacity to detect patterns and stay consistent, machine learning is a great tool for CNS behaviour studies.

It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The field of biogerontology has established itself through significant lines of research in ...